|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Costs and expenses | |||||
| Cost of revenue | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Impairment of intangible assets | |||||
| Impairment charges | |||||
| Total costs and expenses | |||||
| Income (loss) from operations | |||||
| Interest and other, net | |||||
| Income (loss) before income taxes | |||||
| Provision for income taxes | |||||
| Net income (loss) | |||||
| Other comprehensive income (loss) | |||||
| Foreign currency translation | |||||
| Change in fair value of derivatives | |||||
| Total other comprehensive income (loss) | |||||
| Comprehensive income (loss) | |||||
| Net income (loss) per share attributable to common stockholders, basic (in dollars per share) | |||||
| Net income (loss) per share attributable to common stockholders, diluted (in dollars per share) | |||||
| Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, basic (in shares) | |||||
| Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, diluted (in shares) | |||||
Loading...
